Danaher Approached GE About Deal for GE's Life-Sciences Unit
April 25 2018 - 4:27PM
Dow Jones News
By Dana Mattioli, Dana Cimilluca and Thomas Gryta
Danaher Corp. recently expressed interest in a deal for General
Electric Co.'s life- sciences business, but GE didn't engage and
isn't interested in a deal, according to people familiar with the
matter.
The structure of the proposed transaction couldn't be learned,
and the people said there are no active discussions. GE's
life-sciences business, which had about $4.6 billion in revenue
last year, sells lab supplies such as blood-collection kits as well
as equipment for biotechnology drug production and research.
Given how much life-sciences businesses have fetched in recent
deals and analyst estimates, it could be valued at more than $20
billion.
The abortive approach is one of a number GE has received for
various businesses of late as competitors seek to gain advantage
from its weakness, and shows how the once-mighty company's fortunes
have shifted.
(END) Dow Jones Newswires
April 25, 2018 16:12 ET (20:12 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Aug 2024 to Sep 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Sep 2023 to Sep 2024